Two parallel prothrombin activator systems in Australian rough-scaled snake, Tropidechis carinatus. Structural comparison of venom prothrombin activator with blood coagulation factor X

Thrombosis and Haemostasis

Volumn 93, Issue 1, 2005, Pages 40-47

  Abu Reza, Md ^a   Swarup, Sanjay ^a   Manjunatha Kini, R ^a,b  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Factor X; Haemostasis; Prothrombin activation; Snake venom

Indexed keywords

BLOOD CLOTTING FACTOR; BLOOD CLOTTING FACTOR 10; COMPLEMENTARY DNA; PROTHROMBIN; VENOM;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUSTRALIA; CONTROLLED STUDY; DNA SEQUENCE; GENE ACTIVATION; GENE DUPLICATION; HEMOSTASIS; LIVER; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENETIC TREE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; SNAKE; STRUCTURE ACTIVITY RELATION; TISSUE DISTRIBUTION; TISSUE SPECIFICITY;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; FACTOR X; HEMOSTASIS; LIVER; MOLECULAR SEQUENCE DATA; PROTHROMBIN; SEQUENCE ANALYSIS, DNA; SEQUENCE HOMOLOGY; SNAKES; THROMBIN; TISSUE DISTRIBUTION;

EID: 12344283075     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH04-07-0435     Document Type: Article

References (59)

1. Suttie JW, Jackson CM. Prothrombin structure, activation, and biosynthesis. Physiol Rev 1977;57:1-70.
2. Mann KG. The assembly of blood clotting complexes on membranes. Trends Biochem Sci 1987; 12: 229-33.
3. Rosing J, Tans G, Govers-Riemslag JW, et al. The role of phospholipids and factor Va in the prothrombinase complex. J Biol Chem 1980; 255: 274-83.
4. Mann KG, Krishnaswamy S, Lawson JH. Surface-dependent hemostasis. Semin Hematol 1992; 29: 213-26.
5. van Rijn JL, Govers-Riemslag JW, Zwaal RF, et al. Kinetic studies of prothrombin activation: effect of factor Va and phospholipids on the formation of the enzyme-substrate complex. Biochemistry 1984; 23: 4557-64.
6. Markland FS, Jr. Snake venoms. Drugs 1997; 54 Suppl 3: 1-10.
7. Hutton RA, Warrell DA. Action of snake venom components on the haemostatic system. Blood Rev 1993; 7: 176-89.
8. Manjunatha KR, Morita T, Rosing J. Classification and nomenclature of prothrombin activators isolated from snake venoms. Thromb Haemost 2001; 86: 710-11.
9. Joseph JS, Chung MC, Jeyaseelan K, et al. Amino acid sequence of trocarin, a prothrombin activator from Tropidechis carinatus venom: its structural similarity to coagulation factor Xa. Blood 1999; 94: 621-31.
10. Joseph JS, Kini RM. Snake venom prothrombin activators homologous to blood coagulation factor Xa. Haemostasis 2001; 31: 234-40.
11. Rao VS, Joseph JS, Kini RM. Group D prothrombin activators from snake venom are structural homologues of mammalian blood coagulation factor Xa. Biochem J 2003; 369(Pt 3): 635-42.
12. Rosing J, Tans G. Structural and functional properties of snake venom prothrombin activators. Toxicon 1992; 30: 1515-27.
13. Tans G, Govers-Riemslag JW, van Rijn JL, et al. Purification and properties of a prothrombin activator from the venom of Notechis scutatus scutatus. J Biol Chem 1985; 260: 9366-72.
14. Archer RK. The Haemostatic Mechanism In Man And Other Animals. In: Macfarlane RG, editor. Blood coagulation in non-human vertebrates. Academic Press, 1970: 121-32.
15. Bahnak BR, Howk R, Morrissey JH, et al. Steady state levels of factor X mRNA in liver and Hep G2 cells. Blood 1987; 69: 224-30.
16. Miao CH, Leytus SP, Chung DW, et al. Liver-specific expression of the gene coding for human factor X, a blood coagulation factor. J Biol Chem 1992; 267: 7395-01.
17. Rotenberg D, Bamberger ES, Kochva E. Studies on ribonucleic acid synthesis in the venom glands of Vipera palaestinae (Ophidia, Reptilia). Biochem J 1971; 121: 609-12.
18. Paine MJ, Desmond HP, Theakston RD, et al. Gene expression in Echis carinatus (carpet viper) venom glands following milking. Toxicon 1992; 30: 379-86.
19. von Heijne G. A new method for predicting signal sequence cleavage sites. Nucleic Acids Res 1986; 14: 4683-90.
20. Ulrich MM, Furie B, Jacobs MR, et al. Vitamin K-dependent carboxylation. A synthetic peptide based upon the gamma-carboxylation recognition site sequence of the prothrombin propeptide is an active substrate for the carboxylase in vitro. J Biol Chem 1988; 263: 9697-02.
21. Bristol JA, Furie BC, Furie B. Propeptide processing during factor IX biosynthesis. Effect of point mutations adjacent to the propeptide cleavage site. J Biol Chem 1993; 268: 7577-84.
22. Wasley LC, Rehemtulla A, Bristol JA, et al. PACE/ furin can process the vitamin K-dependent pro-factor IX precursor within the secretory pathway. J Biol Chem 1993; 268: 8458-65.
23. Fung MR, Campbell RM, MacGillivray RT. Blood coagulation factor X mRNA encodes a single polypeptide chain containing a prepro leader sequence. Nucleic Acids Res 1984; 12: 4481-92.
24. Lawson JH, Mann KG. Cooperative activation of human factor IX by the human extrinsic pathway of blood coagulation. J Biol Chem 1991; 266: 11317-27.
25. Wesselschmidt R, Likert K, Huang Z, et al. Structural requirements for tissue factor pathway inhibitor interactions with factor Xa and heparin. Blood Coagul Fibrinolysis 1993; 4: 661-69.
26. Ahmad SS, Rawala-Sheikh R, Walsh PN. Components and assembly of the factor X activating complex. Semin Thromb Hemost 1992; 18: 311-23.
27. Rao VS, Swarup S, Kini RM. The catalytic subunit of pseutarin C, a group C prothrombin activator from the venom of Pseudonaja textilis, is structurally similar to mammalian blood coagulation factor Xa. Thromb Haemost 2004; 92: 509-21
28. Jagadeeswaran P, Sheehan JP. Analysis of blood coagulation in the zebrafish. Blood Cells Mol Dis 1999; 25: 239-49.
29. Padmanabhan K, Padmanabhan KP, Talinsky A, et al. Structure of human des(1-45) factor Xa at 2.2 A resolution. J Mol Biol 1993; 232: 947-66.
30. Mizuno H, Fujimoto Z, Atoda H, et al. Crystal structure of an anticoagulant protein in complex with the Gla domain of factor X. Proc Natl Acad Sci U S A 2001; 98: 7230-34.
31. Nelsestuen GL, Broderius M, Martin G. Role of gamma-carboxyglutamic acid. Cation specificity of prothrombin and factor X-phospholipid binding. J Biol Chem 1976; 251(22): 6886-93.
32. Nelsestuen GL, Zytkovicz TH, Howard JB. The mode of action of vitamin K. Identification of gamma-carboxyglutamic acid as a component of prothrombin. J Biol Chem 1974; 249: 6347-50.
33. Prendergast FG, Mann KG. Differentiation of metal ion-induced transitions of prothrombin fragment 1. J Biol Chem 1977; 252: 840-50.
34. Borowski M, Furie BC, Bauminger S, et al. Prothrombin requires two sequential metal-dependent conformational transitions to bind phospholipid. Conformation-specific antibodies directed against the phospholipid-binding site on prothrombin. J Biol Chem 1986; 261: 14969-75.
35. Soriano-Garcia M, Padmanabhan K, de Vos AM, et al. The Ca2+ ion and membrane binding structure of the Gla domain of Ca-prothrombin fragment 1. Biochemistry 1992; 31: 2554-66.
36. Furie B, Furie BC. Molecular basis of vitamin K-dependent gamma-carboxylation. Blood 1990; 75: 1753-62.
37. Drakenberg T, Fernlund P, Roepstorff P, et al. beta-Hydroxyaspartic acid in vitamin K-dependent protein C. Proc Natl Acad Sci U S A 1983; 80: 1802-06.
38. Stenflo J, Lundwall A, Dahlback B. beta-Hydroxyasparagine in domains homologous to the epidermal growth factor precursor in vitamin K-dependent protein S. Proc Natl Acad Sci U S A 1987; 84: 368-72.
39. McMullen BA, Fujikawa K, Kisiel W, et al. Complete amino acid sequence of the light chain of human blood coagulation factor X: evidence for identification of residue 63 as beta-hydroxyaspartic acid. Biochemistry 1983; 22: 2875-84.
40. Fujikawa K, Titani K, Davie EW. Activation of bovine factor X (Stuart factor): conversion of factor Xaalpha to factor Xabeta. Proc Natl Acad Sci U S A 1975; 72: 3359-63.
41. Walsh MT, Watzlawick H, Putnam FW, et al. Effect of the carbohydrate moiety on the secondary structure of beta 2-glycoprotein. I. Implications for the biosynthesis and folding of glycoproteins. Biochemistry 1990; 29: 6250-57.
42. Rudd PM, Joao HC, Coghill E, et al. Glycoforms modify the dynamic stability and functional activity of an enzyme. Biochemistry 1994; 33: 17-22.
43. Kobata A. Structures and functions of the sugar chains of glycoproteins. Eur J Biochem 1992; 209: 483-01.
44. Wang C, Eufemi M, Turano C, et al. Influence of the carbohydrate moiety on the stability of glycoproteins. Biochemistry 1996; 35: 7299-307.
45. Inoue K, Morita T. Identification of O-linked oligosaccharide chains in the activation peptides of blood coagulation factor X. The role of the carbohydrate moieties in the activation of factor X. Eur J Biochem 1993; 218: 153-63.
46. Sinha U, Wolf DL. Carbohydrate residues modulate the activation of coagulation factor X. J Biol Chem 1993; 268: 3048-51.
47. Joseph JS, Valiyaveettil M, Gowda DC, et al. Occurrence of O-linked Xyl-GlcNAc and Xyl-Glc disaccharides in trocarin, a factor Xa homolog from snake venom. J Thromb Haemost 2003; 1: 545-50.
48. Speijer H, Govers-Riemslag JW, Zwaal RF, et al. Prothrombin activation by an activator from the venom of Oxyuranus scutellatus (Taipan snake). J Biol Chem 1986; 261: 13258-67.
49. Hasson SS, Theakston RD, Harrison RA. Cloning of a prothrombin activator-like metalloproteinase from the West African saw-scaled viper, Echis ocellatus. Toxicon 2003; 42: 629-34.
50. Gao R, Manjunatha KR, Gopalakrishnakone P. A novel prothrombin activator from the venom of Micropechis ikaheka: isolation and characterization. Arch Biochem Biophys 2002; 408: 87-92.
51. Silva MB, Schattner M, Ramos CR, et al. A prothrombin activator from Bothrops erythromelas (jararaca-da-seca) snake venom: characterization and molecular cloning. Biochem J 2003; 369: 129-39.
52. Davidson CJ, Tuddenham EG, McVey JH. 450 million years of hemostasis. J Thromb Haemost 2003; 1: 1487-94.
53. Jiang Y, Doolittle RF. The evolution of vertebrate blood coagulation as viewed from a comparison of puffer fish and sea squirt genomes. Proc Natl Acad Sci U S A 2003; 100: 7527-32.
54. Doolittle RF, Feng DF. Reconstructing the evolution of vertebrate blood coagulation from a consideration of the amino acid sequences of clotting proteins. Cold Spring Harb Symp Quant Biol 1987; 52: 869-74.
55. Hackett E, Hann C. Slow clotting of reptile bloods. J Comp Pathol 1967; 77: 175-80.
56. Rowley AF, Hill DJ, Ray CE, et al. Haemostasis in fish - an evolutionary perspective. Thromb Haemost 1997; 77: 227-33.
57. Frost CL, Naude RJ, Oelofsen W, et al. Comparative blood coagulation studies in the ostrich. Immunopharmacology 1999; 45: 75-81.
58. Joseph JS, Chung MC, Mirtschin PJ, et al. Effect of snake venom procoagulants on snake plasma: implications for the coagulation cascade of snakes. Toxicon 2002; 40: 175-83.
59. Racchi M, Watzke HH, High KA, et al. Human coagulation factor X deficiency caused by a mutant signal peptide that blocks cleavage by signal peptidase but not targeting and translocation to the endoplasmic reticulum. J Biol Chem 1993; 268: 5735-40.